The GENA Africa™ Platform
AI‑Driven, Predictive, and Precise Genomic Intelligence for National Health Systems
GENA Africa™, licensed from GENA DNA Global™, delivers AI powered genomic intelligence that makes advanced genetic testing and clinical decision support more accessible and efficient for laboratories, hospitals, health systems, and government partners across the continent. From pre‑diagnosis to analysis, interpretation, and billing, GENA Africa provides end‑to‑end tools that accelerate diagnosis, improve accuracy, and strengthen precision‑medicine delivery.
About the GENA™ Platform
By leveraging AI and machine learning, the GENA platform accelerates diagnosis times by over 95%, ounded over 9 years ago, the GENA™ platform decreases time spent on analysis by 98%. GENA™ has already been used by 1,600 geneticists & has analyzed over 145,000 unique cases. The Artificial Intelligence & Machine Learning genomics SaaS platform is the most used resource of its kind in genomic labs in 40+ countries.
Why Choose The GENA™ Platform?
Genetic testing today is highly reactive. Symptoms start, then tests are ordered, typically many are conducted before a genetic test is considered. GENA was created to solve one core problem: the average time to diagnosis for genetic diseases in adults is 4.8 years, and 6-8 years for children.
GENA Africa™ accelerates the time-to-diagnosis by 95% or more, allowing for:
